BDX BECTON DICKINSON & CO

MIXED Impact: 6/10 8-K
Horizon weeks Filed Apr 2, 2026 Processed 2mo ago SEC 0001628280-26-023185
8-K Item 2.02: Earnings release
Latest settled — T+20d
BDX ▼ -5.85% at T+20d
NEUTRAL call ✗ call lost -5.85% · α vs SPY -14.83% · entry $155.23 → $146.15
Next anchor: T+60d in 20d
Last close $149.99 (close Jun 8) · -3.37% from $155.23 entry
Entry anchored
Apr 2, 03:59 PM ET
via Databento tick
T+1d
-0.17%
call -0.17% · α -0.23%
$154.96
settled 2mo ago
T+5d
+0.13%
call +0.13% · α -4.00%
$155.43
settled 2mo ago
T+20d
-5.85%
call -5.85% · α -14.83%
$146.15
settled 6w ago
T+60d
call — · α —
in 20d

Price Chart

Loading chart...

Executive Summary

BD reported Q1 FY26 adjusted EPS of $2.91, missing consensus by 4.5% and revenue of $4.49B, beating by 2.8%, while reaffirming full-year guidance for New BD. The filing recasts historical financials post-spinoff of Biosciences and Diagnostics business.

Actionable Insight

Despite revenue beat, EPS missed consensus and guidance was maintained, not raised. Monitor upcoming quarters for margin trends in New BD and integration progress of remaining businesses.

Key Facts

  • Adjusted diluted EPS was $2.91, missing consensus of $2.78 by 4.5% (beatMiss: miss)
  • Revenue for New BD was $4.486B, beating consensus of $4.37B by 2.8% (beatMiss: beat)
  • Company reaffirmed full-year adjusted EPS guidance of $12.35–$12.65 for New BD
  • Filing includes recast financials reflecting the spinoff of Biosciences and Diagnostics business completed on February 9, 2026

Financial Impact

Revenue beat by $116M, EPS miss by $0.13

revenueepsguidance

Risk Factors

  • EPS miss despite revenue beat suggests margin pressure or higher-than-expected costs
  • Reaffirmed guidance implies no upward revision despite revenue outperformance

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-023185
Document: bdx-20260402.htm0001628280-26-023185
Document: 0001628280-26-023185-index-headers.html0001628280-26-023185
Document: 0001628280-26-023185-index.html0001628280-26-023185
Document: 0001628280-26-023185.txt0001628280-26-023185
8-K Data (Synthetic)0001628280-26-023185
4 reports for BDX
Performance horizon
Filters
Rows
Reports for BDX — sortable, filterable
Type Now
Jun 3, 2026
6d ago
Insider Cluster
NEUTRAL ★ 2/10
$145.54 $149.44▲ +2.68%▲ +2.28%$149.99 (+3.06%)
May 29, 2026
11d ago
8-K
NEUTRAL ★ 4/10
$146.96 $145.33▼ −1.11%▼ −1.37%$149.99 (+2.06%)
Apr 2, 2026
9w ago
8-K
MIXED ★ 6/10
$155.23 $154.96▼ −0.17%▼ −0.23%$149.99 (−3.37%)
Feb 25, 2026
14w ago
8-K
NEUTRAL ★ 5/10
$176.49 $176.32▼ −0.10%▲ +0.36%$149.99 (−15.01%)
Showing 4 of 4

US Market Status

Market Closed — Opens in 8h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access